In similarity to HER2, HER3 expression is detected in a large fraction of NSCLC [147], and in EGFR-mutated lung cancers the levels are higher when compared to EGFR-wild type lung cancers [148]. This evidence concerns the gene ERBB3 and lung carcinoma.